TW341574B - METHOD AND COMPOSITIONS FOR THE SYNTHESIS OF DIOXOLANE NUCLEOSIDES WITH β-CONFIGURATION the invention relates to methods and compositions for preparing biologically important nucleoside analogues containing 1,3-dioxolane sugar rings. - Google Patents

METHOD AND COMPOSITIONS FOR THE SYNTHESIS OF DIOXOLANE NUCLEOSIDES WITH β-CONFIGURATION the invention relates to methods and compositions for preparing biologically important nucleoside analogues containing 1,3-dioxolane sugar rings.

Info

Publication number
TW341574B
TW341574B TW085115392A TW85115392A TW341574B TW 341574 B TW341574 B TW 341574B TW 085115392 A TW085115392 A TW 085115392A TW 85115392 A TW85115392 A TW 85115392A TW 341574 B TW341574 B TW 341574B
Authority
TW
Taiwan
Prior art keywords
compositions
dioxolane
synthesis
configuration
methods
Prior art date
Application number
TW085115392A
Other languages
English (en)
Inventor
Mansour Tarek
Cimpoia Alex
Bednarski Krzysztof
Original Assignee
Iaf Biochem Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iaf Biochem Int filed Critical Iaf Biochem Int
Application granted granted Critical
Publication of TW341574B publication Critical patent/TW341574B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW085115392A 1995-12-14 1996-12-13 METHOD AND COMPOSITIONS FOR THE SYNTHESIS OF DIOXOLANE NUCLEOSIDES WITH β-CONFIGURATION the invention relates to methods and compositions for preparing biologically important nucleoside analogues containing 1,3-dioxolane sugar rings. TW341574B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9525606.1A GB9525606D0 (en) 1995-12-14 1995-12-14 Method and compositions for the synthesis of dioxolane nucleosides with › - configuration

Publications (1)

Publication Number Publication Date
TW341574B true TW341574B (en) 1998-10-01

Family

ID=10785435

Family Applications (1)

Application Number Title Priority Date Filing Date
TW085115392A TW341574B (en) 1995-12-14 1996-12-13 METHOD AND COMPOSITIONS FOR THE SYNTHESIS OF DIOXOLANE NUCLEOSIDES WITH β-CONFIGURATION the invention relates to methods and compositions for preparing biologically important nucleoside analogues containing 1,3-dioxolane sugar rings.

Country Status (28)

Country Link
US (4) US5922867A (zh)
EP (1) EP0970074B1 (zh)
JP (1) JP3229990B2 (zh)
KR (1) KR100406159B1 (zh)
CN (1) CN1080263C (zh)
AP (1) AP879A (zh)
AT (1) ATE214699T1 (zh)
AU (1) AU706328B2 (zh)
BR (1) BR9612351A (zh)
CA (1) CA2237730C (zh)
DE (1) DE69620042T2 (zh)
DK (1) DK0970074T3 (zh)
EA (1) EA000844B1 (zh)
ES (1) ES2172697T3 (zh)
GB (1) GB9525606D0 (zh)
HK (1) HK1017886A1 (zh)
HU (1) HU224076B1 (zh)
IL (3) IL124663A (zh)
IN (1) IN187349B (zh)
MX (1) MX9804701A (zh)
NO (1) NO309901B1 (zh)
NZ (1) NZ323855A (zh)
OA (1) OA11094A (zh)
PL (1) PL188447B1 (zh)
PT (1) PT970074E (zh)
TW (1) TW341574B (zh)
WO (1) WO1997021706A1 (zh)
ZA (1) ZA9610544B (zh)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6898498A (en) 1997-04-07 1998-10-30 Triangle Pharmaceuticals, Inc. Use of mkc-442 in combination with other antiviral agents
KR100856416B1 (ko) 1998-08-12 2008-09-04 길리애드 사이언시즈, 인코포레이티드 1,3-옥사티올란 뉴클레오시드의 제조 방법
US6979561B1 (en) * 1998-10-09 2005-12-27 Gilead Sciences, Inc. Non-homogeneous systems for the resolution of enantiomeric mixtures
ATE254126T1 (de) 1998-12-23 2003-11-15 Shire Biochem Inc Antivirale nukleosidanaloga
JP2002538780A (ja) * 1999-02-11 2002-11-19 シェア バイオケム インコーポレーテッド ヌクレオシド類似体の立体選択的合成
US6583149B1 (en) 1999-09-24 2003-06-24 Biochem Pharma Inc. Method for the treatment or prevention of viral infection using nucleoside analogues
US6566365B1 (en) * 1999-11-04 2003-05-20 Biochem Pharma Inc. Method for the treatment of Flaviviridea viral infection using nucleoside analogues
WO2001058920A2 (fr) * 2000-02-10 2001-08-16 Mitsui Chemicals, Inc. Procede de production selective d'un anomere derive d'un sucre 1-phosphoryle
DE60127946D1 (de) 2000-02-11 2007-05-31 Shire Biochem Inc Ein stereoselektives verfahren zur herstellung von nukleosidanalogen
WO2002051852A1 (fr) * 2000-12-27 2002-07-04 Mitsui Chemicals, Inc. Procede de production d'un derive de saccharide non naturel
AU2002335489B2 (en) * 2001-03-01 2008-06-05 Abbott Laboratories Polymorphic and other crystalline forms of cis-FTC
WO2003020222A2 (en) * 2001-09-04 2003-03-13 Merck & Co., Inc. PYRROLO[2,3-d]PYRIMIDINES FOR INHIBITING RNA-DEPENDENT RNA VIRAL POLYMERASE
AU2002336864B2 (en) * 2001-11-02 2006-08-17 Shire Biochem Inc. Pharmaceutical compositions for the treatment of leukemia comprising dioxolane nucleosides analogs
AU2002365234B2 (en) * 2001-12-14 2009-01-29 Pharmasset Inc N4-acylcytosine nucleosides for treatment of viral infections
CA2473736C (en) * 2002-01-25 2011-10-11 Shire Biochem Inc. Process for producing dioxolane nucleoside analogues
US6855821B2 (en) 2002-08-06 2005-02-15 Pharmasset, Ltd. Processes for preparing 1,3-dioxolane nucleosides
EP1620479B1 (en) 2002-10-15 2013-07-24 ExxonMobil Chemical Patents Inc. Polyolefin adhesive compositions and articles made therefrom
DE10335061B4 (de) * 2003-07-31 2005-11-17 Wacker-Chemie Gmbh Verfahren zur Herstellung von OH-geschützten [4-(2,6-damino-9H-purin-9-yl)-1,3-dioxolan-2-yl]methanol-Derivaten
CN105039489A (zh) * 2004-02-03 2015-11-11 埃莫里大学 制备1,3-二氧戊环核苷的方法
US7749531B2 (en) * 2005-06-08 2010-07-06 Indicator Systems International Apparatus and method for detecting bacterial growth beneath a wound dressing
BRPI0813036A2 (pt) * 2007-07-30 2017-10-24 Rfs Pharma Llc processo estereosseletivo para preparar derivados do nucleosídeo dioxolana de purina.
CN101862676B (zh) * 2009-04-17 2012-01-25 中国石油化工股份有限公司 大孔径sba-15介孔材料-三氟甲磺酸铜复合催化剂、制备方法及应用
CN103288806A (zh) * 2013-07-02 2013-09-11 山东大学 一种曲沙他滨的合成方法
WO2018022263A1 (en) 2016-07-29 2018-02-01 Exxonmobil Chemical Patents Inc. Polymerization processes using high molecular weight polyhydric quenching agents
JP7337539B2 (ja) * 2018-06-21 2023-09-04 メディヴィル・アクチエボラーグ 白血病療法のための塩基修飾シチジンヌクレオチド
WO2019245444A1 (en) 2018-06-21 2019-12-26 Medivir Ab Base-modified cytidine nucleotides for leukemia therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276151A (en) * 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
CZ123493A3 (en) * 1992-06-22 1994-02-16 Lilly Co Eli Stereoselective anionic glycosylation process

Also Published As

Publication number Publication date
CA2237730A1 (en) 1997-06-19
HUP9901050A3 (en) 2001-05-28
CN1080263C (zh) 2002-03-06
WO1997021706A1 (en) 1997-06-19
EP0970074B1 (en) 2002-03-20
NZ323855A (en) 1999-11-29
IL124663A0 (en) 1998-12-06
CN1208414A (zh) 1999-02-17
AU1089397A (en) 1997-07-03
BR9612351A (pt) 1999-07-13
DK0970074T3 (da) 2002-07-15
OA11094A (en) 2003-03-13
NO982716D0 (no) 1998-06-12
EA000844B1 (ru) 2000-06-26
ZA9610544B (en) 1997-07-29
HK1017886A1 (en) 1999-12-03
EA199800555A1 (ru) 1999-02-25
AP9801252A0 (en) 1998-06-30
PL188447B1 (pl) 2005-02-28
CA2237730C (en) 2001-12-04
US5922867A (en) 1999-07-13
HUP9901050A2 (hu) 2001-04-28
JP3229990B2 (ja) 2001-11-19
AP879A (en) 2000-10-02
KR100406159B1 (ko) 2004-11-16
US20020058670A1 (en) 2002-05-16
IN187349B (zh) 2002-03-30
KR19990072141A (ko) 1999-09-27
PL327443A1 (en) 1998-12-07
IL144155A0 (en) 2002-05-23
PT970074E (pt) 2002-09-30
US6069250A (en) 2000-05-30
GB9525606D0 (en) 1996-02-14
NO309901B1 (no) 2001-04-17
ATE214699T1 (de) 2002-04-15
IL124663A (en) 2001-10-31
HU224076B1 (hu) 2005-05-30
ES2172697T3 (es) 2002-10-01
DE69620042D1 (de) 2002-04-25
DE69620042T2 (de) 2002-10-17
EP0970074A1 (en) 2000-01-12
JP2000501714A (ja) 2000-02-15
US20030060476A1 (en) 2003-03-27
AU706328B2 (en) 1999-06-17
MX9804701A (es) 1998-10-31
NO982716L (no) 1998-06-12
IL144155A (en) 2003-07-06

Similar Documents

Publication Publication Date Title
TW341574B (en) METHOD AND COMPOSITIONS FOR THE SYNTHESIS OF DIOXOLANE NUCLEOSIDES WITH β-CONFIGURATION the invention relates to methods and compositions for preparing biologically important nucleoside analogues containing 1,3-dioxolane sugar rings.
HU912253D0 (en) Process for the production of purinyl-phosphonic acid derivatives
BG100916A (en) Process for the diastereoselective synthesis of nucleoside analogues
TW366350B (en) Processes for the diastereoselective synthesis of nucleosides
UA41261C2 (uk) Спосіб одержання збагачених бета-аномером нуклеозидів
MX2007003085A (es) Preparacion de 2'-fluoro-2'-alquilo sustituido u otras ribofuranosil pirimidinas y purinas opcionalmente sustituidas y sus derivados.
ATE140923T1 (de) Verfahren zur herstellung von n4-acyl-5'-desoxy-5-fluorocytidinderivate
DE3477791D1 (en) Nucleoside process
EP0021231A3 (en) Process for the preparation of 5'-deoxy-5-fluoro uridine and intermediates in this process as well as their application
HK1009451A1 (en) Process for the synthesis of nucleoside analogues
EP0311694A4 (en) Nucleoside derivatives and process for their preparation
JPS6422853A (en) Nucleoside analog
JPS6426594A (en) Nucleotides and antitumor agent
MX9604880A (es) Procedimiento para la sintesis diasteroselectiva de analogos de nucleosido.
GEP20002030B (en) Diastereoselective Synthesis of Nucleosides
JPS5634698A (en) N6-acyl-3'-o(o-nitrobenzyl)adenosine-5'-monophosphate and its preparation
CA2188306A1 (en) Process for the diastereoselective synthesis of nucleoside analogues